News Releases

The information set forth in each press release posted on this page was factually accurate on the date it was issued. While these press releases remain on the Company's website, the Company assumes no duty to update the information to reflect subsequent developments. Consequently, readers of the press releases should not rely upon the information as current or accurate after their issuance dates.

Keyword Search
 
Search by Year
DateTitle 
09/12/17Charles River Research Models in Drug Discovery Award Presented to Sonia Vallabh and Eric Minikel of the Prion AlliancePrinter Friendly Version
09/05/17Charles River Laboratories to Present at September Investor ConferencesPrinter Friendly Version
08/29/17Distinguished Industry Leaders Join Lineup for Inaugural Charles River World Congress on Animal Models in Drug Discovery & DevelopmentPrinter Friendly Version
08/15/17Inaugural Charles River World Congress on Animal Models in Drug Discovery & Development to Explore Trends in Reverse Translational MedicinePrinter Friendly Version
08/09/17Charles River Laboratories Announces Second-Quarter 2017 Results from Continuing OperationsPrinter Friendly Version
08/07/17Charles River Laboratories Acquires Brains On-LinePrinter Friendly Version
07/13/17Charles River Laboratories Schedules Second-Quarter 2017 Earnings Release and Conference CallPrinter Friendly Version
07/05/17Charles River Laboratories Adds Martin Mackay, Ph.D. to Board of DirectorsPrinter Friendly Version
06/05/17Charles River Laboratories to Present at Jefferies Global Healthcare ConferencePrinter Friendly Version
05/16/17Charles River Laboratories Announces Updates to Oncology BusinessPrinter Friendly Version
05/10/17Charles River Laboratories Announces First-Quarter 2017 Results from Continuing OperationsPrinter Friendly Version
04/12/17Charles River Laboratories Schedules First-Quarter 2017 Earnings Release and Conference CallPrinter Friendly Version
04/05/17Nimbus Therapeutics Enters into Strategic Partnership with Charles River Laboratories to Advance New Therapeutic ProgramsPrinter Friendly Version
04/03/17Charles River Laboratories Announces Launch of Triple-Immunodeficient Mouse Model for Oncology ResearchPrinter Friendly Version
03/13/17Charles River Laboratories and Chiesi Farmaceutici SpA Announce Extension of Integrated Respiratory Drug Discovery ProgramPrinter Friendly Version
03/06/17Charles River Laboratories to Present at Raymond James and Barclays ConferencesPrinter Friendly Version
02/14/17Charles River Laboratories Announces Fourth-Quarter and Full-Year 2016 Results from Continuing Operations and Provides 2017 GuidancePrinter Friendly Version
02/09/17Charles River Laboratories Changes Time of Fourth-Quarter 2016 Earnings and 2017 Guidance Conference CallPrinter Friendly Version
01/30/17Charles River Laboratories Announces Progress Update for Collaboration with Moderna TherapeuticsPrinter Friendly Version
01/19/17Charles River Laboratories Schedules Fourth-Quarter 2016 Earnings and 2017 Guidance Release and Conference CallPrinter Friendly Version
01/09/17Charles River Laboratories to Present at J.P. Morgan Healthcare ConferencePrinter Friendly Version
12/01/16Charles River Laboratories Demonstrates Expertise in CRISPR/Cas9 Genome Engineering TechnologyPrinter Friendly Version
11/10/16Charles River Laboratories Presents Robust Program at Neuroscience 2016Printer Friendly Version
11/02/16Charles River Laboratories Announces Third-Quarter 2016 Results from Continuing OperationsPrinter Friendly Version
10/11/16Charles River Announces Extension of Integrated Discovery Program with GenentechPrinter Friendly Version
10/06/16Charles River Laboratories Schedules Third-Quarter 2016 Earnings Release and Conference CallPrinter Friendly Version
09/28/16Charles River Laboratories Acquires Agilux Laboratories, Inc.Printer Friendly Version
09/22/16Charles River Laboratories and The Tri-Institutional Therapeutics Discovery Institute Announce Strategic PartnershipPrinter Friendly Version
09/06/16Charles River Laboratories to Present at September Investor ConferencesPrinter Friendly Version
08/08/16Charles River Laboratories Announces Partnership with the Milner Therapeutics Institute and ConsortiumPrinter Friendly Version
08/03/16Charles River Laboratories Announces Second-Quarter 2016 Results from Continuing OperationsPrinter Friendly Version
07/11/16Charles River Laboratories Schedules Second-Quarter 2016 Earnings Release and Conference CallPrinter Friendly Version
06/27/16Charles River Laboratories Acquires Blue Stream LaboratoriesPrinter Friendly Version
06/06/16Charles River Laboratories to Present at Jefferies and William Blair ConferencesPrinter Friendly Version
06/06/16Moderna Therapeutics and Charles River Laboratories Announce Strategic Collaboration to Scale Moderna’s Nonclinical Development Efforts for Novel mRNA TherapeuticsPrinter Friendly Version
05/04/16Charles River Laboratories Announces First-Quarter 2016 Results from Continuing OperationsPrinter Friendly Version
04/13/16Charles River Laboratories and BioMotiv Enter into Strategic PartnershipPrinter Friendly Version
04/07/16Charles River Laboratories Schedules First-Quarter 2016 Earnings Release and Conference CallPrinter Friendly Version
04/04/16Charles River Laboratories Completes the Acquisition of WIL ResearchPrinter Friendly Version
03/07/16Charles River Laboratories to Present at Raymond James ConferencePrinter Friendly Version
02/10/16Charles River Laboratories Announces Fourth-Quarter and Full-Year 2015 Results from Continuing Operations and Provides 2016 GuidancePrinter Friendly Version
01/20/16Charles River Laboratories Schedules Fourth-Quarter 2015 Earnings and 2016 Guidance Release and Conference CallPrinter Friendly Version
01/07/16Charles River Laboratories to Acquire WIL ResearchPrinter Friendly Version
12/08/15Charles River Laboratories Expands Long-Standing Collaboration with The Michael J. Fox Foundation for Parkinson’s ResearchPrinter Friendly Version
11/18/15Charles River Laboratories Acquires Oncotest GmbHPrinter Friendly Version
11/04/15Charles River Laboratories Announces Third-Quarter 2015 Results from Continuing OperationsPrinter Friendly Version
10/19/15Charles River Laboratories Presents 25 Scientific Posters at Neuroscience 2015Printer Friendly Version
10/08/15Charles River Laboratories Schedules Third-Quarter 2015 Earnings Release and Conference CallPrinter Friendly Version
10/07/15Charles River Announces New and Continued Drug Discovery CollaborationsPrinter Friendly Version
09/15/15Charles River Laboratories to Present at Morgan Stanley ConferencePrinter Friendly Version
07/30/15Charles River Laboratories and AstraZeneca Renew Strategic Partnership AgreementPrinter Friendly Version
07/30/15Charles River Laboratories Announces Second-Quarter 2015 Results from Continuing OperationsPrinter Friendly Version
07/24/15Charles River Laboratories Completes the Acquisition of Celsis International Ltd.Printer Friendly Version
07/09/15Charles River Laboratories to Acquire Celsis International Ltd.Printer Friendly Version
07/07/15Charles River Laboratories Schedules Second-Quarter 2015 Earnings Release and Conference CallPrinter Friendly Version
06/01/15Charles River Laboratories to Present at Jefferies ConferencePrinter Friendly Version
05/04/15Charles River Laboratories to Present at Baird and Deutsche Bank ConferencesPrinter Friendly Version
04/29/15Charles River Laboratories Announces First-Quarter 2015 Results from Continuing OperationsPrinter Friendly Version
04/09/15Charles River Laboratories Schedules First-Quarter 2015 Earnings Release and Conference CallPrinter Friendly Version
03/02/15Charles River Laboratories to Present at March Investor ConferencesPrinter Friendly Version
02/24/15Charles River Laboratories Announces Planned Management ChangesPrinter Friendly Version
02/11/15Charles River Laboratories to Present at Leerink Global Healthcare ConferencePrinter Friendly Version
02/10/15Charles River Laboratories Announces Fourth-Quarter and Full-Year 2014 Results from Continuing Operations and Provides 2015 GuidancePrinter Friendly Version
01/26/15Charles River Laboratories Schedules Fourth-Quarter 2014 Earnings and 2015 Guidance Release and Conference CallPrinter Friendly Version
01/12/15Charles River Laboratories to Present at J.P. Morgan Healthcare ConferencePrinter Friendly Version
10/29/14Charles River Laboratories Announces Third-Quarter 2014 Results from Continuing OperationsPrinter Friendly Version
10/08/14Charles River Laboratories Schedules Third-Quarter 2014 Earnings Release and Conference CallPrinter Friendly Version
09/08/14Charles River Laboratories to Present at Morgan Stanley Global Healthcare ConferencePrinter Friendly Version
08/06/14Charles River Laboratories Announces Second-Quarter 2014 Results from Continuing OperationsPrinter Friendly Version
07/24/14Charles River Laboratories to Webcast Investor MeetingPrinter Friendly Version
07/07/14Charles River Laboratories Schedules Second-Quarter 2014 Earnings Release and Conference CallPrinter Friendly Version
06/02/14Charles River Laboratories to Present at Jefferies and William Blair ConferencesPrinter Friendly Version
05/05/14Charles River Laboratories to Present at Baird’s Growth Stock ConferencePrinter Friendly Version
04/30/14Charles River Laboratories Announces First-Quarter 2014 Results from Continuing OperationsPrinter Friendly Version
04/07/14Charles River Laboratories Schedules First-Quarter 2014 Earnings Release and Conference CallPrinter Friendly Version
03/31/14Charles River Laboratories Completes the Acquisition of the CRO Services Division of Galapagos NVPrinter Friendly Version
03/13/14Charles River Laboratories to Acquire the CRO Services Division of Galapagos NVPrinter Friendly Version
03/03/14Charles River Laboratories to Present at Cowen and Raymond James ConferencesPrinter Friendly Version
02/11/14Charles River Laboratories Announces Fourth-Quarter and Full-Year 2013 Results from Continuing Operations and Provides 2014 GuidancePrinter Friendly Version
01/27/14Charles River Laboratories Schedules Fourth-Quarter 2013 Earnings and 2014 Guidance Release and Conference CallPrinter Friendly Version
01/13/14Charles River Laboratories to Present at J.P. Morgan Healthcare ConferencePrinter Friendly Version
12/09/13Charles River Laboratories Announces Organizational Changes to Enhance Global CapabilitiesPrinter Friendly Version
12/03/13Charles River Laboratories Adds Craig B. Thompson, M.D. to Board of DirectorsPrinter Friendly Version
11/11/13Charles River Laboratories to Present at Credit Suisse Healthcare ConferencePrinter Friendly Version
10/29/13Charles River Laboratories Announces Third-Quarter 2013 Results from Continuing OperationsPrinter Friendly Version
09/26/13Charles River Laboratories Schedules Third-Quarter 2013 Earnings Release and Conference CallPrinter Friendly Version
09/26/13Charles River Laboratories Appoints John Crowley as Corporate Senior Vice President, Corporate Controller and Chief Accounting OfficerPrinter Friendly Version
09/09/13Charles River Laboratories to Present at Morgan Stanley Global Healthcare ConferencePrinter Friendly Version
07/31/13Charles River Laboratories Announces Second-Quarter 2013 Results from Continuing OperationsPrinter Friendly Version
07/02/13Charles River Laboratories Schedules Second-Quarter 2013 Earnings Release and Conference CallPrinter Friendly Version
06/03/13Charles River Laboratories to Present at June Investor ConferencesPrinter Friendly Version
05/06/13Charles River Laboratories to Present at Baird’s Growth Stock ConferencePrinter Friendly Version
05/01/13Charles River Laboratories Announces First-Quarter 2013 Results from Continuing OperationsPrinter Friendly Version
04/08/13Charles River Laboratories Schedules First-Quarter 2013 Earnings Release and Conference CallPrinter Friendly Version
03/01/13Charles River Laboratories to Present at March Investor ConferencesPrinter Friendly Version
02/13/13Charles River Laboratories Announces Fourth-Quarter and Full-Year 2012 Results from Continuing OperationsPrinter Friendly Version
01/22/13Charles River Laboratories Schedules Fourth-Quarter and Full-Year 2012 Earnings Release and Conference CallPrinter Friendly Version
01/07/13Charles River Laboratories Completes Acquisition of Majority Ownership of Vital RiverPrinter Friendly Version
01/07/13Charles River Laboratories to Present at J.P. Morgan Healthcare ConferencePrinter Friendly Version
12/12/12Charles River Laboratories Provides 2013 Financial GuidancePrinter Friendly Version
10/30/12Charles River Laboratories Announces Third-Quarter 2012 Results from Continuing OperationsPrinter Friendly Version
10/30/12Charles River Laboratories to Expand Research Models Business in ChinaPrinter Friendly Version
10/17/12Charles River Laboratories Enters Strategic Partnership with AstraZenecaPrinter Friendly Version
09/06/12Charles River Opens New Biomedical Diagnostic FacilityPrinter Friendly Version
08/29/12Charles River Acquires AccugenixPrinter Friendly Version
08/07/12Charles River Announces Second-Quarter 2012 Results from Continuing OperationsPrinter Friendly Version
05/02/12Charles River Announces First-Quarter 2012 Results from Continuing OperationsPrinter Friendly Version
02/13/12Charles River Announces Fourth-Quarter and Full-Year 2011 Results from Continuing OperationsPrinter Friendly Version
12/14/11Charles River Provides 2012 Financial GuidancePrinter Friendly Version
11/01/11Charles River Announces Third-Quarter 2011 Results from Continuing OperationsPrinter Friendly Version
09/29/11Scientific Consortium Awarded Knockout Mouse Project Grant from the National Institutes of HealthPrinter Friendly Version
08/23/11Charles River Announces New Business AlignmentPrinter Friendly Version
08/02/11Charles River Announces Second-Quarter 2011 Results from Continuing OperationsPrinter Friendly Version
05/03/11Charles River Announces First-Quarter 2011 Results from Continuing OperationsPrinter Friendly Version
03/03/11Charles River Announces Agreement to Supply Pfizer's Genetically Modified Research ModelsPrinter Friendly Version
02/24/11Charles River Implements $150 Million Accelerated Stock Repurchase ProgramPrinter Friendly Version
02/08/11Charles River Announces Fourth-Quarter and Full-Year 2010 Results from Continuing OperationsPrinter Friendly Version
01/24/11Charles River Laboratories Adds Robert J. Bertolini and Richard F. Wallman to Board of DirectorsPrinter Friendly Version
12/14/10Charles River Discusses Business Outlook with InvestorsPrinter Friendly Version
11/03/10Charles River Announces Third-Quarter 2010 ResultsPrinter Friendly Version
10/13/10Charles River Announces Exclusive License with Transposagen Biopharmaceuticals, Inc.Printer Friendly Version
08/27/10Charles River Implements $300 Million Accelerated Stock Repurchase ProgramPrinter Friendly Version
08/02/10Charles River Announces Second-Quarter 2010 ResultsPrinter Friendly Version
07/29/10Charles River Announces Mutual Termination of Acquisition Agreement with WuXi PharmaTechPrinter Friendly Version
07/15/10Proxy Governance Supports Charles River's Proposed Acquisition of WuXiPrinter Friendly Version
07/13/10Charles River and WuXi File Revised Investor PresentationPrinter Friendly Version
07/01/10Charles River Commences Mailing of Proxy Materials in Connection with WuXi PharmaTech AcquisitionPrinter Friendly Version
04/26/10Charles River Laboratories and WuXi PharmaTech to Combine, Creating the First Global CRO Offering Fully Integrated Early-Stage Drug Development Services to Clients WorldwidePrinter Friendly Version
04/26/10Charles River Announces First-Quarter 2010 ResultsPrinter Friendly Version
04/15/10Charles River Shanghai Receives OECD CertificationPrinter Friendly Version
02/08/10Charles River Announces Fourth-Quarter and Full-Year 2009 Results and Provides 2010 GuidancePrinter Friendly Version
01/11/10Charles River to Suspend Operations of Preclinical Services Massachusetts to Balance Global Capacity with DemandPrinter Friendly Version
11/03/09Charles River Announces Third-Quarter 2009 ResultsPrinter Friendly Version
10/07/09Charles River Shanghai Facility Receives AAALAC, CCAC and SLAC AccreditationsPrinter Friendly Version
08/04/09Charles River Announces Second-Quarter 2009 ResultsPrinter Friendly Version
07/01/09Charles River Announces RMS Succession Plan and Organizational EnhancementsPrinter Friendly Version
05/05/09Charles River Announces First-Quarter 2009 ResultsPrinter Friendly Version
04/03/09Charles River to Acquire Piedmont Research CenterPrinter Friendly Version
02/09/09Charles River Announces Fourth-Quarter and Full-Year 2008 Results and 2009 GuidancePrinter Friendly Version
11/19/08Charles River Promotes Foster Jordan to Corporate Senior Vice PresidentPrinter Friendly Version
11/05/08Charles River Announces Third-Quarter 2008 ResultsPrinter Friendly Version
10/30/08Charles River Adds Veterinary School Dean Dr. Deborah Kochevar to Board of DirectorsPrinter Friendly Version
10/15/08Charles River Expands Global Footprint with Shanghai Facility OpeningPrinter Friendly Version
10/08/08Charles River Selected to Host Association of Clinical Pharmacology Units' Annual ConferencePrinter Friendly Version
09/29/08Charles River Announces Promotion of Dr. Christophe Berthoux as Major Step in Realignment of Its Global Sales and Marketing OrganizationPrinter Friendly Version
09/15/08Charles River Acquires MIR Preclinical ServicesPrinter Friendly Version
09/09/08Charles River Completes the Acquisition of NewLab BioQuality AGPrinter Friendly Version
08/05/08Charles River Announces Second-Quarter 2008 ResultsPrinter Friendly Version
07/29/08Charles River Supports the National Cancer Institute and Establishes New RMS OperationsPrinter Friendly Version
05/06/08Charles River Announces First-Quarter 2008 ResultsPrinter Friendly Version
02/11/08Charles River Announces Fourth-Quarter and Full-Year 2007 Results from Continuing OperationsPrinter Friendly Version
12/12/07Charles River Laboratories Reaffirms Guidance for 2007 and Provides Guidance for 2008Printer Friendly Version
12/03/07Charles River Laboratories Appoints Iron Mountain CEO Richard Reese to Board of DirectorsPrinter Friendly Version
11/05/07Charles River Laboratories Announces Third-Quarter 2007 Results from Continuing OperationsPrinter Friendly Version
11/02/07Charles River Laboratories Strengthens Operations with Global Corporate Senior Vice President AppointmentsPrinter Friendly Version
10/24/07Charles River Laboratories Adds Nancy T. Chang to Board of DirectorsPrinter Friendly Version
08/27/07Charles River Laboratories Announces Plan to Construct New Preclinical Services Facility in QuebecPrinter Friendly Version
08/07/07Charles River Laboratories Announces Second-Quarter 2007 Results from Continuing OperationsPrinter Friendly Version
06/19/07Charles River Laboratories' CEO James C. Foster Named An Ernst & Young Entrepreneur Of The Year(R) Award RecipientPrinter Friendly Version
06/14/07Charles River Laboratories Completes Chinese Joint VenturePrinter Friendly Version
05/08/07Charles River Laboratories Announces First-Quarter 2007 Results from Continuing OperationsPrinter Friendly Version
04/24/07Charles River Laboratories Appoints Cheri Walker, Ph.D. as Corporate Senior Vice President, Corporate DevelopmentPrinter Friendly Version
03/23/07Charles River Laboratories Expands Global Reach to ChinaPrinter Friendly Version
03/16/07Charles River Laboratories Appoints Stephanie Wells as Corporate Senior Vice President, Marketing and Chief Marketing OfficerPrinter Friendly Version
03/06/07Charles River Laboratories Opens State-of-the-Art Preclinical Services Facility in MassachusettsPrinter Friendly Version
02/12/07Charles River Laboratories Announces Fourth-Quarter and Full-Year 2006 Results from Continuing OperationsPrinter Friendly Version
01/03/07Charles River Laboratories' Endosafe(R)-Pts(TM) Completes Journey to the International Space StationPrinter Friendly Version
12/13/06Charles River Laboratories Reaffirms GAAP Guidance for 2006 and Provides Guidance for 2007Printer Friendly Version
12/06/06Charles River Laboratories Clinical Services -- Northwest Kinetics Achieves Mortara Certified Partner StatusPrinter Friendly Version
11/21/06Charles River Laboratories Schedules 2007 Guidance Release and Conference CallPrinter Friendly Version
11/13/06Charles River Laboratories to Present at Credit Suisse Healthcare ConferencePrinter Friendly Version
11/06/06Charles River Laboratories Announces Third-Quarter 2006 Results from Continuing OperationsPrinter Friendly Version
10/30/06Charles River Laboratories Acquires Northwest Kinetics, Inc.Printer Friendly Version
10/25/06Charles River Laboratories Initiates Enhanced IT Solutions For Life Sciences CustomersPrinter Friendly Version
10/05/06Charles River Laboratories Schedules Third-Quarter 2006 Earnings Release and Conference CallPrinter Friendly Version
09/22/06Charles River Laboratories to Present at UBS Global Life Sciences ConferencePrinter Friendly Version
09/22/06Charles River Laboratories Awarded $111.6 Million National Cancer Institute Contract; Charles River to Construct New Facility in Support of NCI and RMS Geographic ExpansionPrinter Friendly Version
09/11/06Charles River Laboratories to Present at Bear Stearns Healthcare ConferencePrinter Friendly Version
09/05/06Charles River Laboratories to Present at Thomas Weisel Healthcare ConferencePrinter Friendly Version
08/16/06Charles River Laboratories Completes Sale of Clinical Phase II - IV BusinessPrinter Friendly Version
08/08/06Charles River Laboratories Announces Second-Quarter 2006 Results from Continuing OperationsPrinter Friendly Version
07/18/06Charles River Laboratories Receives FDA Approval for Sale and Marketing of First Portable Endotoxin Test System, the Endosafe-PTS(TM); Breakthrough One-Button Technology Revolutionizes Endotoxin DetectionPrinter Friendly Version
07/11/06Charles River Laboratories Schedules Second-Quarter 2006 Earnings Release and Conference CallPrinter Friendly Version
06/26/06Charles River Laboratories to Present at Jefferies Life Sciences ConferencePrinter Friendly Version
06/12/06Charles River Laboratories Closes Sale of $300 Million Convertible Senior Notes and Reaffirms 2006 GuidancePrinter Friendly Version
06/12/06Charles River Laboratories to Present at Goldman Sachs Global Healthcare ConferencePrinter Friendly Version
06/06/06Charles River Laboratories Prices $300 Million Convertible Senior Notes; Company to Repurchase Approximately $150 Million of Common StockPrinter Friendly Version
06/05/06Charles River Laboratories to Offer $300 Million Convertible Senior Notes; Company Intends to Repurchase Approximately $125 Million of Common StockPrinter Friendly Version
05/15/06Charles River Laboratories to Present at Bank of America Health Care ConferencePrinter Friendly Version
05/09/06Charles River Laboratories Announces First-Quarter 2006 Results; Enters into Agreement to Sell Phase II - IV Clinical Business to Kendle; Provides Revised Guidance for 2006; Increases Stock Repurchase AuthorizationPrinter Friendly Version
04/18/06Charles River Laboratories Implements BioTrove High-Throughput SNP Genotyping SystemPrinter Friendly Version
04/12/06Charles River Laboratories Schedules First-Quarter 2006 Earnings Release and Conference CallPrinter Friendly Version
03/27/06Charles River Laboratories Appoints Nicholas Ventresca as Corporate Senior Vice President, Information Technology, and Chief Information OfficerPrinter Friendly Version
03/22/06Charles River Laboratories Signs Licensing Agreement with Washington UniversityPrinter Friendly Version
03/08/06Charles River Laboratories to Present at Lehman Brothers Global Healthcare ConferencePrinter Friendly Version
03/06/06Charles River Laboratories to Present at Cowen & Co. Health Care ConferencePrinter Friendly Version
02/10/06Charles River Laboratories to Present at UBS Healthcare Services ConferencePrinter Friendly Version
02/08/06Charles River Laboratories Announces Fourth-Quarter and Full-Year 2005 ResultsPrinter Friendly Version
01/16/06Charles River Laboratories Appoints John C. Ho, M.D. as Senior Vice President, Corporate StrategyPrinter Friendly Version
01/09/06Charles River Laboratories Schedules Fourth-Quarter and Full-Year 2005 Earnings Release and Conference CallPrinter Friendly Version
01/09/06Charles River Laboratories Becomes Deltagen's Exclusive, Worldwide Custodian, Supplier of Knockout Mice RepositoryPrinter Friendly Version
01/06/06Charles River Laboratories to Present at JPMorgan Healthcare ConferencePrinter Friendly Version
01/05/06Charles River Laboratories Signs Licensing Agreement with Luminex® CorporationPrinter Friendly Version
12/14/05Charles River Laboratories Provides Guidance for 2006 and Reaffirms Guidance for 2005Printer Friendly Version
12/12/05Charles River Laboratories Accelerates Vesting of Options; One-Time Charge of $0.01 Reduces 2005 GAAP GuidancePrinter Friendly Version
12/12/05Charles River Laboratories to Webcast Investor MeetingPrinter Friendly Version
11/14/05Charles River Laboratories to Present at CSFB Healthcare ConferencePrinter Friendly Version
11/04/05Charles River Laboratories Extends Global Alliance with Rules-Based Medicine, Inc.Printer Friendly Version
10/28/05Charles River Laboratories Announces Executive Vice President Appointments in Corporate Finance, Corporate Human Resources & AdministrationPrinter Friendly Version
10/27/05Charles River Laboratories Announces Third-Quarter 2005 Results; Sales Reach $274 million; GAAP Earnings Per Share of $0.44 and $0.57 on a Non-GAAP Basis; Company Updates Guidance for 2005Printer Friendly Version
10/17/05Charles River Laboratories Clinical Services and DataLabs Announce EDC PartnershipPrinter Friendly Version
10/05/05Charles River Laboratories Schedules Third-Quarter 2005 Earnings Release and Conference CallPrinter Friendly Version
09/29/05Charles River Laboratories Announces David J. Elliott to Join Charles River as Corporate ControllerPrinter Friendly Version
09/08/05Charles River Laboratories Updates Outlook for Third Quarter of 2005Printer Friendly Version
09/01/05Charles River Laboratories to Present at September ConferencesPrinter Friendly Version
07/28/05Charles River Laboratories Announces Second-Quarter 2005 ResultsPrinter Friendly Version
07/05/05Charles River Laboratories Schedules Second-Quarter 2005 Earnings Release and Conference CallPrinter Friendly Version
06/13/05Charles River Laboratories Celebrates 5 Years on New York Stock ExchangePrinter Friendly Version
06/01/05Charles River Laboratories to Present at Goldman Sachs Healthcare ConferencePrinter Friendly Version
05/03/05Charles River Laboratories Announces Strong First-Quarter 2005 ResultsPrinter Friendly Version
04/25/05Charles River Laboratories to Present at May ConferencesPrinter Friendly Version
04/06/05Charles River Laboratories Schedules First-Quarter 2005 Earnings Release and Conference CallPrinter Friendly Version
03/30/05Charles River Laboratories Reaffirms First-Quarter 2005 EPS GuidancePrinter Friendly Version
03/28/05Charles River Laboratories to Redeem 3.50% Senior Convertible Debentures Due 2022Printer Friendly Version
03/01/05Charles River Laboratories to Present at SG Cowen Health Care ConferencePrinter Friendly Version
02/14/05Charles River Laboratories Announces Strong Fourth-Quarter and Full-Year 2004 ResultsPrinter Friendly Version
02/01/05Charles River Laboratories to Present at UBS Global Healthcare Services ConferencePrinter Friendly Version
01/18/05Charles River Laboratories Schedules Fourth-Quarter 2004 Earnings Release and Conference CallPrinter Friendly Version
01/03/05Charles River Laboratories to Present at JPMorgan Healthcare ConferencePrinter Friendly Version
12/15/04Charles River Laboratories Reaffirms Non-GAAP Guidance for 2004 and 2005 and Updates 2005 GAAP EPSPrinter Friendly Version
12/08/04Charles River Laboratories Names Dr. Nancy Gillett President of Global Pre-Clinical ServicesPrinter Friendly Version
12/01/04Charles River Laboratories Announces Departure of Dennis Shaughnessy, General CounselPrinter Friendly Version
11/01/04Charles River Laboratories to Present at November ConferencesPrinter Friendly Version
10/28/04Charles River Laboratories Announces Record Third-Quarter 2004 Results and Provides Guidance for Fourth Quarter 2004Printer Friendly Version
10/20/04Charles River Laboratories Announces Completion of Inveresk MergerPrinter Friendly Version
09/28/04Charles River Laboratories Schedules Third-Quarter 2004 Earnings Release and Conference CallPrinter Friendly Version
09/08/04Charles River Laboratories and Inveresk Announce Date for Special Shareholder MeetingsPrinter Friendly Version
09/02/04Charles River Laboratories to Present at September ConferencesPrinter Friendly Version
08/10/04Charles River Laboratories Revises Management Incentive PlanPrinter Friendly Version
07/28/04Charles River Laboratories Announces Record Second-Quarter 2004 Results and Increases Guidance for 2004Printer Friendly Version
07/21/04FTC Grants Anti-Trust Clearance of Proposed Charles River/Inveresk MergerPrinter Friendly Version
07/06/04Charles River Laboratories Schedules Second-Quarter 2004 Earnings Release and Conference CallPrinter Friendly Version
07/01/04Charles River Laboratories Raises Guidance for Second Quarter 2004Printer Friendly Version
07/01/04Charles River Laboratories and Inveresk to Combine to Create a Leading Global Partner to the Pharmaceutical and Biotechnology IndustryPrinter Friendly Version
06/04/04Charles River Laboratories Elects Linda McGoldrick to Board of DirectorsPrinter Friendly Version
05/24/04Charles River Laboratories Management to Present at June ConferencesPrinter Friendly Version
05/24/04Charles River Laboratories Management to Webcast Investor DayPrinter Friendly Version
04/28/04Charles River Laboratories Reports Record First-Quarter Sales and Non-GAAP Earnings and Raises Guidance for 2004Printer Friendly Version
04/27/04Charles River Laboratories Management to Present at May ConferencesPrinter Friendly Version
04/01/04Charles River Laboratories Schedules First-Quarter 2004 Earnings Release and Conference CallPrinter Friendly Version
02/25/04Charles River Laboratories Management to Present at March ConferencesPrinter Friendly Version
02/10/04Charles River Laboratories Reports Record Year in 2003, Strong Fourth-Quarter Results and Improving Outlook for 2004Printer Friendly Version
01/12/04Charles River Laboratories Schedules Fourth-Quarter 2003 Earnings Release and Conference CallPrinter Friendly Version
01/12/04Charles River Laboratories ReconfirmsGuidance; 2003 at High End of RangesPrinter Friendly Version
01/08/04Charles River Laboratories Acquires River Valley Farms; Strengthens CRL's Position as Leading Provider of Outsourced Medical Device ServicesPrinter Friendly Version
12/30/03Charles River Laboratories Management to Address JPMorgan Healthcare ConferencePrinter Friendly Version
11/13/03Charles River Laboratories Names Scientific Advisory Board; Board of Scientists Will Strengthen Scientific and Technology Opportunities for CompanyPrinter Friendly Version
10/29/03Charles River Laboratories Announces Third-Quarter 2003 Results, Confirms Outlook for 2003, and Provides Outlook for Continued Growth in 2004Printer Friendly Version
09/02/03Charles River Laboratories Updates Outlook for 2003Printer Friendly Version
08/14/03Multimedia Available: Charles River Laboratories Launches Endosafe-PTSPrinter Friendly Version
08/14/03Charles River Laboratories Launches Endosafe-PTSPrinter Friendly Version
07/29/03Charles River Laboratories Announces Second-Quarter 2003 Results and Confirms Outlook for 2003Printer Friendly Version
06/30/03Charles River Laboratories To Announce Second Quarter 2003 Earnings Release and Conference CallPrinter Friendly Version
05/21/03Charles River Laboratories Ranked #4 in Globe 100Printer Friendly Version
04/30/03Charles River Laboratories Announces First-Quarter 2003 Results and Provides Outlook for 2003Printer Friendly Version
04/28/03Charles River Laboratories Recognized in Herald HundredPrinter Friendly Version
04/07/03Charles River Laboratories Collaborates with Xenogen Biosciences in Strategic Marketing AgreementPrinter Friendly Version
04/03/03Charles River Laboratories and Proteome Systems Ltd Launch Proteomic Services; Open House To Feature State-of-the Art LaboratoryPrinter Friendly Version
03/17/03Charles River Laboratories Confirms First-Quarter Guidance in Conjunction With S.G. Cowen ConferencePrinter Friendly Version
03/07/03Charles River Laboratories to Address SG Cowen ConferencePrinter Friendly Version
02/26/03Charles River Laboratories Announces Appointment of George E. Massaro to Board of DirectorsPrinter Friendly Version
02/20/03Charles River Laboratories Management to Address Lehman Brothers and Wachovia Securities ConferencesPrinter Friendly Version
02/03/03Charles River Laboratories Announces Strong Fourth-Quarter and Full-Year 2002 Results and Provides Positive Outlook for 2003Printer Friendly Version
01/21/03Charles River Laboratories Management to Address UBS Warburg Global Healthcare Services ConferencePrinter Friendly Version
01/06/03Charles River Laboratories Increases Stake in Charles River JapanPrinter Friendly Version
01/06/03Charles River Laboratories Updates Earnings Expectations in Conjunction with JPMorgan H&Q ConferencePrinter Friendly Version
12/16/02Charles River Laboratories Announces Promotion of Real H. Renaud to Executive Vice PresidentPrinter Friendly Version
10/29/02Charles River Laboratories Announces Third-Quarter 2002 Results, Provides Positive Outlook for 2002 and 2003, and Elects New Board MemberPrinter Friendly Version
10/11/02James C. Foster, Charles River's Chairman and CEO Named ''Entrepreneur of the Year'' by Forbes MagazinePrinter Friendly Version
10/07/02Charles River Laboratories Reconfirms Previous Earnings Expectations in Conjunction With UBS Warburg ConferencePrinter Friendly Version
10/02/02Charles River Laboratories and Proteome Systems Launch Joint Venture in Proteomics ServicesPrinter Friendly Version
10/01/02Charles River Acquires Springborn Laboratories, Inc.Printer Friendly Version
09/30/02Charles River Laboratories Third-Quarter 2002 Earnings Conference Call ScheduledPrinter Friendly Version
09/12/02Charles River Laboratories Management to Address Bear Stearns Healthcare ConferencePrinter Friendly Version
09/09/02Charles River Laboratories Appoints Two Senior ExecutivesPrinter Friendly Version
09/04/02Charles River Introduces 'In Vitro' Test Product For the Detection of Harmful Contaminants in DrugsPrinter Friendly Version
09/03/02Charles River Added to Standard & Poor's S&P MidCap 400 IndexPrinter Friendly Version
07/30/02Charles River Again Delivers Strong Earnings Growth; Eighth Consecutive Quarter of Consistently Strong Financial PerformancePrinter Friendly Version
07/03/02Charles River Laboratories Second Quarter 2002 Earnings Conference Call ScheduledPrinter Friendly Version
06/14/02Charles River Fully Retires LBO-Related DebtPrinter Friendly Version
06/10/02Charles River Acquires Leading Irish Pre-Clinical Services CompanyPrinter Friendly Version
05/21/02Charles River Laboratories Named 'Company of the Year' by The Boston GlobePrinter Friendly Version
05/01/02Sales and Earnings at Charles River Show Continued Growth; Seventh Consecutive Post-IPO Quarter of Strong Financial PerformancePrinter Friendly Version
04/10/02Charles River Laboratories First Quarter 2002 Earnings Conference Call ScheduledPrinter Friendly Version
02/21/02Charles River Announces Share Distribution By Investor GroupPrinter Friendly Version
02/12/02Charles River Laboratories Sets Purchase Price In Tender Offer and Consent Solicitation For Its 13.5% Senior Subordinated Notes Due 2009Printer Friendly Version
02/06/02Charles River Reports Strong Growth in Fourth Quarter and YearPrinter Friendly Version
01/29/02Charles River Laboratories Announces Receipt of Requisite Consents from Holders of its Outstanding 13.5% Senior Subordinated Notes Due 2009Printer Friendly Version
01/23/02Charles River Laboratories Fourth Quarter 2001 Earnings Conference Call ScheduledPrinter Friendly Version
01/17/02Charles River Laboratories Prices $175 Million Offering Of Senior Convertible DebenturesPrinter Friendly Version
01/15/02Charles River Laboratories Announces Cash Tender Offer for Outstanding Senior Subordinated Notes and Consent SolicitationPrinter Friendly Version
01/15/02Charles River Laboratories Announces $150 Million Offering of Senior Convertible DebenturesPrinter Friendly Version
01/14/02Charles River Acquires 'In Vitro' Technology PlatformPrinter Friendly Version
01/07/02Charles River Sees Strong Earnings Growth in 2002Printer Friendly Version
01/04/02Charles River Laboratories CEO to Address JPMorgan H&Q Healthcare ConferencePrinter Friendly Version
12/13/01Charles River Announces Board of Directors Changes; Credit Rating UpgradePrinter Friendly Version
12/05/01Charles River Announces Share Distribution by Investor GroupPrinter Friendly Version
11/08/01Charles River Announces Partial Share Distribution by DLJ Merchant BankingPrinter Friendly Version
10/31/01Sales and Earnings at Charles River Show Continued StrengthPrinter Friendly Version
09/28/01Charles River Laboratories Third Quarter 2001 Earnings Conference Call ScheduledPrinter Friendly Version
09/27/01Charles River Collaborates with Medical College of Wisconsin For Consomic Rat Models Used in Applied Genomics ResearchPrinter Friendly Version
09/25/01Charles River Awarded National Cancer Institute ContractPrinter Friendly Version
09/24/01Charles River Laboratories Raises Third Quarter Earnings GuidancePrinter Friendly Version
08/02/01Charles River Reports Strong Growth in Sales and EarningsPrinter Friendly Version
07/30/01Charles River Laboratories Second Quarter 2001 Earnings Conference Call ScheduledPrinter Friendly Version
07/20/01Charles River to Acquire Genetic Models Inc.Printer Friendly Version
07/20/01Charles River Prices Offering of 8,000,000 SharesPrinter Friendly Version
07/13/01Charles River and the Jackson Laboratory Cooperate in International Supply of Mouse Research ModelsPrinter Friendly Version
07/11/01Charles River and Sangamo Biosciences to Collaborate in the Development of Transgenic Rat ModelsPrinter Friendly Version
07/05/01Charles River Enters Into Cloning Partnership With Advanced Cell TechnologyPrinter Friendly Version
07/05/01Charles River to Acquire Genetic Models Inc.Printer Friendly Version
06/22/01Charles River Laboratories Announces Intention to File a Registration StatementPrinter Friendly Version
06/14/01Charles River Laboratories Raises Second Quarter Earnings GuidancePrinter Friendly Version
05/03/01Charles River Reports Strong First Quarter Sales and EarningsPrinter Friendly Version
04/27/01Charles River Laboratories First Quarter 2001 Earnings Conference Call ScheduledPrinter Friendly Version
03/21/01Charles River Closes Offering of 8,050,000 SharesPrinter Friendly Version
03/16/01Charles River Prices Offering of 7,000,000 SharesPrinter Friendly Version
02/27/01Charles River Completes Acquisition of PrimedicaPrinter Friendly Version
02/15/01Charles River Laboratories International Announces Filing of Registration Statement for Public Offering of Common StockPrinter Friendly Version
02/15/01Charles River Laboratories International Makes AnnouncementPrinter Friendly Version
02/14/01Charles River Reports Continued Growth in Sales and EarningsPrinter Friendly Version
02/09/01Charles River Laboratories Fourth Quarter 2000 Earnings Conference Call ScheduledPrinter Friendly Version
02/07/01Charles River Agrees to Acquire PrimedicaPrinter Friendly Version
01/30/01Charles River Laboratories Credit Ratings UpgradedPrinter Friendly Version
01/08/01Charles River Acquires Pathology Associates InternationalPrinter Friendly Version
12/21/00Charles River to Acquire Pathology Associates InternationalPrinter Friendly Version
12/11/00Charles River Laboratories International, Inc. Responds to Stock DeclinePrinter Friendly Version
12/04/00Charles River Enters Into Mouse Cloning Partnership With Tufts UniversityPrinter Friendly Version
11/27/00Outlook at Charles River Exceeding Estimates for Fourth QuarterPrinter Friendly Version
11/01/00Third Quarter Sales Surge at Charles River LaboratoriesPrinter Friendly Version
10/23/00Charles River Laboratories Third Quarter 2000 Earnings Conference Call ScheduledPrinter Friendly Version
08/02/00Charles River Laboratories Announces Second Quarter Results; Charles River Laboratories International, Inc. Reports Second Quarter 2000 Sales Increase of 32.6%Printer Friendly Version
07/10/00Charles River Laboratories Inc., to Partially Redeem Senior Subordinated NotesPrinter Friendly Version
06/26/00Charles River Laboratories International, Inc. Raises $224 Million In Initial Public Offering of Common StockPrinter Friendly Version
05/09/00Charles River Laboratories Announces First Quarter ResultsPrinter Friendly Version
04/25/00Charles River Laboratories Holdings Announces Filing Of Registration Statement For Initial Public Offering Of Common StockPrinter Friendly Version
03/24/00Charles River Announces Year-End ResultsPrinter Friendly Version